Tianda Pharmaceuticals Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was HKD 509.96 million compared to HKD 474.33 million a year ago. Net loss was HKD 19.77 million compared to HKD 27.14 million a year ago.

Basic loss per share from continuing operations was HKD 0.0092 compared to HKD 0.0126 a year ago. Diluted loss per share from continuing operations was HKD 0.0092 compared to HKD 0.0126 a year ago.